From Oncology to Society: Rethinking and Expanding Precision Medicine

Introduction

Precision medicine is often associated with cancer care. Advances in tumor sequencing, targeted therapies, and biomarker-guided clinical trials have positioned oncology as the flagship application of this approach, shaping public perception to equate precision medicine exclusively with cancer treatment. However, what if these advancements extend beyond oncology? At its core, precision medicine is about understanding variability in genetics, environment, and lifestyle to improve health outcomes for all individuals, not only patients with cancer.

How Oncology Came to Dominate Precision Medicine

Tumour profiling enabled clinicians to match patients with therapies based on genetic mutations, improving treatment specificity and outcomes in certain cancers. High-profile research initiatives and clinical trials further reinforced the association between precision medicine and cancer care. As a result, precision medicine became widely viewed as a cancer-centered innovation, despite its broader scientific foundation.

Everyday Health Is Biologically Complex

Common health concerns such as fatigue, sleep disturbances, weight fluctuations, headaches, gastrointestinal discomfort, and stress-related symptoms are frequently managed using generalized advice or symptomatic treatments.

However, these conditions are influenced by multiple biological systems, including metabolic regulation, hormonal rhythms, immune function, and inflammatory pathways. Lifestyle factors such as diet, physical activity, stress exposure, and sleep patterns interact dynamically with individual biology.

When care is delivered using standardized approaches without accounting for individual variability, management often becomes reactive and reliant on trial and error. 

A precision-oriented approach seeks to understand underlying patterns rather than solely addressing symptoms.

Expanding Precision Beyond Disease Labels

Precision medicine in everyday health emphasizes patterns rather than diagnoses alone. This includes understanding:

• When symptoms occur

• What triggers or alleviates them

• How symptoms fluctuate over time

• How an individual responds to small behavioral or environmental changes

This model does not aim to replace healthcare professionals or eliminate pharmacological treatments. Instead, it supports more informed decision-making, reduces unnecessary interventions, and encourages targeted strategies that align with personal biological characteristics.

By integrating data such as lifestyle tracking, biomarkers, and individual health history, precision approaches can refine preventive and therapeutic care.

A Population Health Opportunity

If precision medicine remains limited to oncology, its broader societal impact will be constrained. Expanding personalization to everyday health could enhance quality of life, improve preventive strategies, and potentially reduce long-term healthcare costs.

Population-level implementation of precision principles may support earlier identification of risk patterns, more effective lifestyle interventions, and more efficient resource allocation. Over time, this shift could contribute to more sustainable healthcare systems.

To realize this potential, interdisciplinary collaboration, robust evidence generation, and equitable access to personalized tools will be essential.

Conclusion

Precision medicine is not exclusively an oncology innovation. While cancer research has driven much of its visibility, the core principles of individual variability and tailored decision-making apply to all aspects of health.

By extending precision approaches beyond disease labels and into everyday wellness, healthcare systems can move toward more proactive, preventive, and personalized care. Continued research, responsible implementation, and inclusive access will determine how broadly precision medicine can transform global health.

References

Ashley, E. A. (2016). Towards precision medicine. Nature Reviews Genetics, 17(9), 507–522. https://doi.org/10.1038/nrg.2016.86

Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. The New England Journal of Medicine, 372(9), 793–795. https://doi.org/10.1056/NEJMp1500523

Hood, L., & Price, N. D. (2014). Demystifying disease, democratizing health care. Science Translational Medicine, 6(225), 225ed5. https://doi.org/10.1126/scitranslmed.3008665

Assessed and Endorsed by the MedReport Medical Review Board